MedTrace Logo

Early Diagnosis of Patients With Mild Cognitive Impairment Through the Parameterization of Functional Tests.

NCT03851198 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2023-12-07

No results posted yet for this study

Summary

The present study aims to develop an index formed by the variables, functional tests, scales and instruments that best discriminate between healthy subjects and subjects with MCI and that allows the stratification of different levels of severity of MCI, and to validate new systems for the early diagnosis of subjects with mild cognitive impairment.

Conditions

Interventions

PROCEDURE

Standard Care or Usual Clinical Practice

The guidelines for the management according to the mild cognitive impairment in primary care will be the treatment guidelines for the Standard Care.

Sponsors & Collaborators

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-01
Primary Completion
2021-07-01
Completion
2021-09-01

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03851198 on ClinicalTrials.gov